Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.58 USD | -0.50% | -1.69% | +9.43% |
Apr. 16 | BioNexus Gene Lab Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 29 | BioNexus Gene Lab Corp. Provides Information to Shareholders | CI |
Financials (USD)
Sales 2022 | 10.93M | Sales 2023 | 9.77M | Capitalization | 9.36M |
---|---|---|---|---|---|
Net income 2022 | - | Net income 2023 | -2M | EV / Sales 2022 | 14.9 x |
Net cash position 2022 | 2.06M | Net cash position 2023 | 5.78M | EV / Sales 2023 | 0.37 x |
P/E ratio 2022 |
-461
x | P/E ratio 2023 |
-3.2
x | Employees | 30 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 35.63% |
1 day | -0.50% | ||
1 week | -1.69% | ||
Current month | -6.44% | ||
1 month | -6.71% | ||
3 months | -49.12% | ||
6 months | +70.64% | ||
Current year | +9.43% |
Managers | Title | Age | Since |
---|---|---|---|
Lee Su-Leng Tan
CEO | Chief Executive Officer | 40 | 23-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chee Keong Yap
BRD | Director/Board Member | 68 | 22-03-06 |
Wei Foong Lim
BRD | Director/Board Member | 48 | Dec. 10 |
Lee Su-Leng Tan
CEO | Chief Executive Officer | 40 | 23-07-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-15 | 0.58 | -0.50% | 135 974 |
24-05-14 | 0.5829 | +0.48% | 92,782 |
24-05-13 | 0.5801 | -0.03% | 71,054 |
24-05-10 | 0.5803 | -2.47% | 58,467 |
24-05-09 | 0.595 | +0.85% | 29,190 |
Delayed Quote Nasdaq, May 15, 2024 at 03:49 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+9.43% | 10.3M | |
+29.50% | 49.18B | |
+0.80% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.73% | 26.09B | |
-22.83% | 18.71B | |
+8.21% | 13.26B | |
+32.42% | 12.32B | |
-1.28% | 11.99B |
- Stock Market
- Equities
- BGLC Stock